O2h Ventures — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Hawkhill Therapeuticshawkhilltherapeutics.comApr 2026
BiotechDundee, Scotland
Timothy Jason Sparey(Executive Officer)Antoine Boulanger(Executive Officer)Francisca Peixoto(Executive Officer)Christopher Andrew Woodland(Executive Officer, Director)Mary Canning(Executive Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.